×
Vaso EBITDA 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Vaso ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Vaso EBITDA 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Vaso ebitda from 2010 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$202.3B
Intuitive Surgical (ISRG)
$191.3B
Edwards Lifesciences (EW)
$44.5B
Alcon (ALC)
$42.5B
IQVIA Holdings (IQV)
$36.3B
IDEXX Laboratories (IDXX)
$33.9B
DexCom (DXCM)
$31.3B
Waters (WAT)
$22.2B
STERIS (STE)
$20.6B
SONOVA HOLDING (SONVY)
$19.8B
Hologic (HOLX)
$16.5B
Fresenius Medical Care AG KGaA (FMS)
$13.3B
Sysmex ADR (SSMXY)
$11.7B
Globus Medical (GMED)
$11.4B
Penumbra (PEN)
$9.2B
Masimo (MASI)
$9B
Glaukos (GKOS)
$8.3B
Teleflex (TFX)
$8.2B
Integer Holdings (ITGR)
$4.5B
PROCEPT BioRobotics (PRCT)
$4.4B
Veracyte (VCYT)
$3.2B
Inari Medical (NARI)
$3.1B
LivaNova (LIVN)
$2.5B
Tandem Diabetes Care (TNDM)
$2.4B
Nihon Kohden (NHNKY)
$2.4B
TransMedics (TMDX)
$2.1B
Elekta AB (EKTAY)
$2B
Integra LifeSciences Holdings (IART)
$1.7B
RxSight (RXST)
$1.4B
Alphatec Holdings (ATEC)
$1.3B